1-4 of 4
Christie Fanton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

NKTR-255 Vs Placebo to Enhance Complete Responses and Durability Following CD19-Directed CAR-T Therapy in Patients with Relapsed/ Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Sairah Ahmed, John F. DiPersio, James H Essell, Catherine S. Diefenbach, Miguel Angel Perales, Cristina Castilla-Llorente, Saurabh Dahiya, Sohail Chaudhry, Heng Xu, Yi Liu, Christie Fanton, Zachary Lee, Mario Q. Marcondes, Mary Tagliaferri, Jonathan Zalevsky, David B. Miklos, Cameron J. Turtle, Joseph P. McGuirk
Journal: Blood
Blood (2024) 144 (Supplement 1): 2068.
https://doi.org/10.1182/blood-2024-203576
Published: 2024
Journal Articles

Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

Krina Patel, Nina Shah, Alan Tan, Andrew J Cowan, Cameron J. Turtle, Craig C Hofmeister, Taewoong Choi, Hayder Saeed, Julio C. Chavez, Matthew J. Pianko, Mitul Gandhi, Sohail A. Chaudhry, Zachary Lee, Neha Dixit, Christie Fanton, Xiaoli Wang, Heng Xu, Mario Q. Marcondes, Mary A. Tagliaferri, Jonathan Zalevsky, Miguel-Angel Perales
Journal: Blood
Blood (2022) 140 (Supplement 1): 10357–10359.
https://doi.org/10.1182/blood-2022-162539
Published: 2022
Journal Articles

A Phase 2/3, Randomized, Double Blind, Placebo-Controlled, Multicenter Study of NKTR-255 Vs Placebo Following CD-19 Directed CAR-T Therapy in Patients with Relapsed/Refractory Large B-Cell Lymphoma

Miguel-Angel Perales, Sairah Ahmed, Saurabh Dahiya, Peter A. Riedell, Joseph P. McGuirk, Olalekan O. Oluwole, Sohail A. Chaudhry, Zachary Lee, Stanley Dai, Neha Dixit, Christie Fanton, Mario Q. Marcondes, Jonathan Zalevsky, Mary A. Tagliaferri, Cameron J. Turtle
Journal: Blood
Blood (2022) 140 (Supplement 1): 7488–7490.
https://doi.org/10.1182/blood-2022-162511
Published: 2022
Journal Articles

The Pan-PIM Kinase Inhibitor LGH447 Shows Activity In PIM2-Dependent Multiple Myeloma and In AML Models

Pablo D Garcia, PhD, John L Langowski, Ph.D., Jocelyn Holash, Ph.D., Matthew Burger, Ph.D., Richard Zang, Ph.D., Tatiana Zavorotinskaya, PhD, Christie Fanton, PhD, Abdel Saci, Ph.D., Joseph Growney, Ph.D., K. Gary Vanasse, M.D.
Journal: Blood
Blood (2013) 122 (21): 1666.
https://doi.org/10.1182/blood.V122.21.1666.1666
Published: 2013